
Jean F. Voltaire
Examiner (ID: 18083, Phone: (571)272-3953 , Office: P/2466 )
| Most Active Art Unit | 2466 |
| Art Unit(s) | 2466, 2417 |
| Total Applications | 487 |
| Issued Applications | 381 |
| Pending Applications | 55 |
| Abandoned Applications | 68 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9570059
[patent_doc_number] => 20140187773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-03
[patent_title] => 'TENOFOVIR ALAFENAMIDE HEMIFUMARATE'
[patent_app_type] => utility
[patent_app_number] => 14/197873
[patent_app_country] => US
[patent_app_date] => 2014-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5449
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14197873
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/197873 | Tenofovir alafenamide hemifumarate | Mar 4, 2014 | Issued |
Array
(
[id] => 11176847
[patent_doc_number] => 09408824
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-09
[patent_title] => 'Compositions and products containing S-equol, and methods for their making'
[patent_app_type] => utility
[patent_app_number] => 14/198192
[patent_app_country] => US
[patent_app_date] => 2014-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 11
[patent_no_of_words] => 15116
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14198192
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/198192 | Compositions and products containing S-equol, and methods for their making | Mar 4, 2014 | Issued |
Array
(
[id] => 11336647
[patent_doc_number] => 20160362402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-15
[patent_title] => 'NOVEL COMPOUNDS HAVING ANTI-ALLODYNIC AND ANTIHYPERALGESIC ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 15/121649
[patent_app_country] => US
[patent_app_date] => 2014-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3766
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15121649
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/121649 | NOVEL COMPOUNDS HAVING ANTI-ALLODYNIC AND ANTIHYPERALGESIC ACTIVITY | Feb 26, 2014 | Abandoned |
Array
(
[id] => 11176945
[patent_doc_number] => 09408921
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-09
[patent_title] => 'Antineoplastic hydrogels, and enzyme-instructed preparations thereof'
[patent_app_type] => utility
[patent_app_number] => 14/189185
[patent_app_country] => US
[patent_app_date] => 2014-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12931
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14189185
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/189185 | Antineoplastic hydrogels, and enzyme-instructed preparations thereof | Feb 24, 2014 | Issued |
Array
(
[id] => 9686625
[patent_doc_number] => 20140243390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-28
[patent_title] => 'NOVEL KIF5B-RET FUSION MOLECULES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/187280
[patent_app_country] => US
[patent_app_date] => 2014-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 43226
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14187280
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/187280 | KIF5B-RET fusion molecules and uses thereof | Feb 22, 2014 | Issued |
Array
(
[id] => 10077213
[patent_doc_number] => 09115054
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-25
[patent_title] => 'Tetrahydronaphthalenyl compounds useful as sipi agonists'
[patent_app_type] => utility
[patent_app_number] => 14/185164
[patent_app_country] => US
[patent_app_date] => 2014-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 30800
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14185164
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/185164 | Tetrahydronaphthalenyl compounds useful as sipi agonists | Feb 19, 2014 | Issued |
Array
(
[id] => 9671755
[patent_doc_number] => 20140235618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-21
[patent_title] => 'METHODS FOR TREATMENT OF ATOPIC DERMATITIS AND INFLAMMATORY SKIN DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 14/183810
[patent_app_country] => US
[patent_app_date] => 2014-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1852
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14183810
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/183810 | METHODS FOR TREATMENT OF ATOPIC DERMATITIS AND INFLAMMATORY SKIN DISORDERS | Feb 18, 2014 | Abandoned |
Array
(
[id] => 14452357
[patent_doc_number] => 10322125
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-18
[patent_title] => TGF-beta enhancing compositions for cartilage repair and methods related thereto
[patent_app_type] => utility
[patent_app_number] => 14/768563
[patent_app_country] => US
[patent_app_date] => 2014-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9121
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14768563
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/768563 | TGF-beta enhancing compositions for cartilage repair and methods related thereto | Feb 17, 2014 | Issued |
Array
(
[id] => 9538469
[patent_doc_number] => 20140163116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'METHOD OF TREATING CANCER USING A CURCUMIN DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 14/181581
[patent_app_country] => US
[patent_app_date] => 2014-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 22034
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14181581
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/181581 | METHOD OF TREATING CANCER USING A CURCUMIN DERIVATIVE | Feb 13, 2014 | Abandoned |
Array
(
[id] => 14029415
[patent_doc_number] => 10226438
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-12
[patent_title] => Sobetirome in the treatment of myelination diseases
[patent_app_type] => utility
[patent_app_number] => 14/888577
[patent_app_country] => US
[patent_app_date] => 2014-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 9783
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14888577
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/888577 | Sobetirome in the treatment of myelination diseases | Feb 4, 2014 | Issued |
Array
(
[id] => 9671855
[patent_doc_number] => 20140235718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-21
[patent_title] => 'PHENOXYETHOXY COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/171817
[patent_app_country] => US
[patent_app_date] => 2014-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5834
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14171817
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/171817 | Phenoxyethoxy compounds | Feb 3, 2014 | Issued |
Array
(
[id] => 9511025
[patent_doc_number] => 20140147517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-29
[patent_title] => 'Use of Amisulpride as an Anti-Emetic'
[patent_app_type] => utility
[patent_app_number] => 14/172194
[patent_app_country] => US
[patent_app_date] => 2014-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3720
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14172194
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/172194 | Use of amisulpride as an anti-emetic | Feb 3, 2014 | Issued |
Array
(
[id] => 10975469
[patent_doc_number] => 20140378505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-25
[patent_title] => 'SNS-595 AND METHODS OF USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/171673
[patent_app_country] => US
[patent_app_date] => 2014-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4040
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14171673
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/171673 | SNS-595 AND METHODS OF USING THE SAME | Feb 2, 2014 | Abandoned |
Array
(
[id] => 10540680
[patent_doc_number] => 09265784
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-02-23
[patent_title] => 'Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine'
[patent_app_type] => utility
[patent_app_number] => 14/169015
[patent_app_country] => US
[patent_app_date] => 2014-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12370
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14169015
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/169015 | Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine | Jan 29, 2014 | Issued |
Array
(
[id] => 9635502
[patent_doc_number] => 20140213612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-31
[patent_title] => 'PPAR GAMMA AGONISTS FOR TREATMENT OF MULTIPLE SCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 14/162723
[patent_app_country] => US
[patent_app_date] => 2014-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4479
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14162723
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/162723 | PPAR gamma agonists for treatment of multiple sclerosis | Jan 22, 2014 | Issued |
Array
(
[id] => 14029429
[patent_doc_number] => 10226445
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-12
[patent_title] => Pharmaceutical preparations
[patent_app_type] => utility
[patent_app_number] => 14/761474
[patent_app_country] => US
[patent_app_date] => 2014-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6198
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14761474
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/761474 | Pharmaceutical preparations | Jan 14, 2014 | Issued |
Array
(
[id] => 10457942
[patent_doc_number] => 20150342957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-03
[patent_title] => 'COMBINATION'
[patent_app_type] => utility
[patent_app_number] => 14/759314
[patent_app_country] => US
[patent_app_date] => 2014-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17406
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14759314
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/759314 | COMBINATION | Jan 7, 2014 | Abandoned |
Array
(
[id] => 12246290
[patent_doc_number] => 09919053
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-20
[patent_title] => 'Cabazitaxel composition'
[patent_app_type] => utility
[patent_app_number] => 14/655214
[patent_app_country] => US
[patent_app_date] => 2013-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2410
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14655214
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/655214 | Cabazitaxel composition | Dec 22, 2013 | Issued |
Array
(
[id] => 11634009
[patent_doc_number] => 09655965
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-23
[patent_title] => 'Radiosensitizer compounds for use in combination with radiation'
[patent_app_type] => utility
[patent_app_number] => 14/654165
[patent_app_country] => US
[patent_app_date] => 2013-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 20120
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14654165
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/654165 | Radiosensitizer compounds for use in combination with radiation | Dec 19, 2013 | Issued |
Array
(
[id] => 11634009
[patent_doc_number] => 09655965
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-23
[patent_title] => 'Radiosensitizer compounds for use in combination with radiation'
[patent_app_type] => utility
[patent_app_number] => 14/654165
[patent_app_country] => US
[patent_app_date] => 2013-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 20120
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14654165
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/654165 | Radiosensitizer compounds for use in combination with radiation | Dec 19, 2013 | Issued |